Comparison of nifekalant and amiodarone for resuscitation of out-of-hospital cardiopulmonary arrest resulting from shock-resistant ventricular fibrillation

PURPOSE: Nifekalant is a pure potassium channel blocker that has been used to treat ventricular tachyarrhythmias since 1999 in Japan. Intravenous amiodarone was approved later than nifekalant in Japan, and it is still unclear which of the two agents is superior. The aim of this study was to compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Harayama, Nobuya, Nihei, Shun-ichi, Nagata, Keiji, Isa, Yasuki, Goto, Kei, Aibara, Keiji, Kamochi, Masayuki, Sata, Takeyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126999/
https://www.ncbi.nlm.nih.gov/pubmed/24389941
http://dx.doi.org/10.1007/s00540-013-1775-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126999/
https://www.ncbi.nlm.nih.gov/pubmed/24389941
http://dx.doi.org/10.1007/s00540-013-1775-5

Ejemplares similares